Expanding to the spatial dimension in metabolomics with MALDI Imaging Mass Spectrometry
Bruker: Expanding to the spatial dimension in metabolomics with MALDI Imaging Mass Spectrometry
Traditional LC-based metabolomics workflows give maximum depth of information for bulk materials and are critical for untargeted profiling. Additional spatial information is possible with the versatility of the timsTOF platform and enables you to do both traditional and spatial workflows on the same instrument. MALDI Imaging is a true multiomics technique that allows for spatial determination of metabolites and lipids in tissue, as well as expanding targeted analysis to glycans and proteins. The addition of microGRID technology enables true 5 micron imaging for maximum biological information gain.
What to expect?
- Live presentation from Bruker’s Billerica demo facility to see ease of use of the timsTOF fleX platform
Who should attend?
- Scientists and researchers interested in expanding their metabolomics workflows to the spatial dimension, scientists working with spatial distribution of small molecule biologics
- MALDI Imaging users wanting to expand their workflows to small molecules
- Anyone interested in learning more about MALDI Imaging capabilities
Presenter: Kate Stumpo, Ph.D. (Business Development Manager, SpatialOMx, Bruker Scientific, LLC, Billerica, MA, USA)
Presenter: Josh Fischer, Ph.D. (Applications Scientist, Imaging, Bruker Scientific, LLC, Billerica, MA, USA)
Presenter: Ethan Yang, Ph.D. (Applications Lead, Imaging, Bruker Scientific, LLC, Billerica, MA, USA)